| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 253597-19-2 | 4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid bis((1-oxobutoxy)methyl) ester | C25H29Cl2NO8 |
| 253597-20-5 | 4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3-pyridinecarboxylic acid methyl ester;H 168/79 | C15H15Cl2NO2 |
| 253605-31-1 | N-tert-Butylhydroxylamine acetate | C4H11NO.C2H4O2 |
| 253607-91-9 | Difluoro(5-Oxahexacyclo[5.4.1.02,6.03,10.04,8.09,12]Dodec-4-Yl)Acetic Acid | C13H12F2O3 |
| 253677-29-1 | 5-Chloro-2-((tert-butoxycarbonyl)amino)benzoic acid | C12H14ClNO4 |
| 253678-67-0 | Undecyl beta-D-maltopyranoside | C23H44O11 |
| 253678-93-2 | 3'-Cyano-3-Biphenylcarboxylic Acid | C14H9NO2 |
| 253688-60-7 | N-[6-(2-Hydroxyethoxy)-5-(2-Methoxyphenoxy)-2,2'-Bipyrimidin-4-Yl]-4-(1-Hydroxy-2-Methyl-2-Propanyl)Benzenesulfonamide | C27H29N5O7S |
| 253688-91-4 | (1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(3-methyl-2-butenylidene)(tricyclohexylphosphine)ruthenium(II) | C44H67Cl2N2PRu |
| 253768-88-6 | N-Phenoxycarbonyl Paroxetine;Phenyl (3S,4R)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-piperidinecarboxylate | C26H24FNO5 |
| 253801-04-6 | 1H-Indazole-5-carbaldehyde | C8H6N2O |
| 253801-11-5 | 2-(4-Formylphenyl)Isonicotinonitrile | C13H8N2O |
| 253863-00-2 | 4-((5-((4-(3-Chlorophenyl)-3-oxo-1-piperazinyl)methyl)-1H-imidazol-1-yl)methyl)benzonitrile monohydrochloride;L 778123 | C22H20ClN5O.HCl |
| 253863-19-3 / 66018-38-0 | (5Z)-7-Oxozeaenol;(3S,5Z,8S,9S,11E)-3,4,9,10-Tetrahydro-8,9,16-trihydroxy-14-methoxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione; C 292; F 152; FR 148083; L 783279; LL-Z 1640-2; f 152 A1 | C19H22O7 |
| 253870-02-9 | 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | C8H9NO3 |
| 253878-93-2 | 3-Cyanobiphenyl-3-carboxylic acid | |
| 254100-95-3 | 2-Methyl-2-Propanyl [2-({[(2,5-Dioxo-1-Pyrrolidinyl)Oxy]Carbonyl}Amino)Ethyl]Carbamate | C12H19N3O6 |
| 254101-10-5 | Boc-L-beta-glutamic acid 5-benzyl ester;Boc-L-beta-homoaspartic acid 5-benzyl ester; Boc-beta-Glu(OBzl)-OH | C17H23NO6 |
| 254101-11-6 | Boc-O-benzyl-L-beta-homothreonine;(3R,4R)-4-(Benzyloxy)-3-((tert-butoxycarbonyl)amino)pentanoic acid | C17H25NO5 |
| 254109-22-3 | 4-Amino-5-methylamino-2',7'-difluorofluorescein diacetate;3',6'-Bis(acetyloxy)-4-amino-2',7'-difluoro-5-(methylamino)spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one; DAF-FM DA | C25H18F2N2O7 |
| 254438-54-5 | (2S,3S)-3-Amino-2-hydroxyheptanoic acid | C7H15NO3 |
| 254452-86-3 | (3S,5R,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3,5-dihydroxy-6-heptenoic acid | C25H24FNO4 |
| 254452-88-5 | (3S,5R,E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid | C25H24FNO4 |
| 254454-54-1 | 1-Boc-3-iodoazetidine;1-tert-Butoxycarbonyl-3-iodoazetidine | C8H14INO2 |
| 254732-51-9 | 2-Chloro-3-(trifluoroMethyl)quinoxaline | |
| 254740-64-2 | 4'-((2-Butyl-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)-N-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-(1,1'-biphenyl)-2-sulfonamide | C32H40N4O5S |
| 254749-11-6 | 2-Chloro-4-cyanobenzenesulfonyl chloride;2-Chloro-4-cyanobenzene-1-sulfonyl chloride | C7H3Cl2NO2S |
| 254749-13-8 | 5-(2,4-Dichloro-Phenyl)-Oxazole-4-Carboxylic Acid Ethyl Ester | C12H9Cl2NO3 |
| 254750-02-2 | PF 03491390;Emricasan; IDN 6556; N-(2-(tert-butyl)phenyl)-2-oxoglycyl-N-((1S)-1-(carboxymethyl)-2-oxo-3-(2,3,5,6-tetrafluorophenoxy)propyl)-L-alaninamide | C26H27F4N3O7 |
| 254753-54-3 | (4S)-Monastrol;(4S)-1,2,3,4-Tetrahydro-4-(3-hydroxyphenyl)-6-methyl-2-thioxo-5-pyrimidinecarboxylic acid ethyl ester | C14H16N2O3S |
| 254755-24-3 | 9,9-Dihexylfluorene-2,7-bis(boronic acid pinacol ester);2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9,9-dihexylfluorene | C37H56B2O4 |
| 254762-66-8 | Amino(2-Bromophenyl)Acetic Acid | C8H8BrNO2 |
| 254877-67-3 | Ataciguat;5-Chloro-2-(((5-chlorothien-2-yl)sulfonyl)amino)-N-(4-((morpholin-4-yl)sulfonyl)phenyl)benzamide; HMR 1766 | C21H19Cl2N3O6S3 |
| 254880-25-6 | 3-Chloro-4-Hydrazinobenzonitrile | C7H6ClN3 |
| 254881-77-1 | (2R,4S)-1-tert-Butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylate;(2R,4S)-4-Amino-1,2-pyrrolidinedicarboxylic acid 1-(1,1-dimethylethyl) 2-methyl ester | C11H20N2O4 |
| 254882-06-9 | (2S,4R)-1-tert-Butyl 2-methyl 4-hydroxypiperidine-1,2-dicarboxylate;(2S,4R)-N-Boc-4-Hydroxypiperidine-2-carboxylic acid methyl ester | C12H21NO5 |
| 254882-09-2 | (2S,4S)-4-Amino-1,2-piperidinedicarboxylic acid 1-(1,1-dimethylethyl) 2-methyl ester | C12H22N2O4 |
| 254882-14-9 | (2S,4S)-1-tert-Butyl 2-methyl 4-hydroxypiperidine-1,2-dicarboxylate | C12H21NO5 |
| 254883-43-7 | 4-(2-Chloro-5-Methylphenoxy)Piperidine | C12H16ClNO |
| 254886-77-6 | Kushenol X | C25H28O7 |
| 254887-17-7 | 4-Bromo-1-Methyl-2-(Methylsulfonyl)Benzene | C8H9BrO2S |
| 254887-18-8 | 4-Bromo-1-(Bromomethyl)-2-(Methylsulfonyl)Benzene | C8H8Br2O2S |
| 254893-03-3 | [4-(3-Oxocyclobutyl)Phenyl]Boronic Acid | C10H11BO3 |
| 254900-07-7 | 5-Methacryloxy-6-hydroxynorbornane-2-carboxylic-6-lactone;4-Oxa-5-oxotricyclo(4.2.1.0(3,7))nonan-2-yl methacrylate | C12H14O4 |
| 254964-60-8 | Tasquinimod;4-Hydroxy-5-methoxy-N-methyl-1-methyl-2-oxo-N-(4-trifluoromethylphenyl)-1,2-dihydroquinoline-3-carboxamide; ABR 215050; N-Methyl-N-(4-trifluoromethylphenyl)-1,2-dihydro-4-hydroxy-5-methoxy-1-methyl-2-oxoquinoline-3-carboxamide | C20H17F3N2O4 |
| 254966-93-3 | Potassium Acetate | C2H3KO2 |
| 254972-49-1 | Dichloro(1,3-dihydro-1,3-bis(2,4,6-trimethylphenyl)-2H-imidazol-2-ylidene)(3-phenyl-1H-inden-1-ylidene)(tricyclohexylphosphine)ruthenium;catMETium RF1 | C54H67Cl2N2PRu |
| 254990-08-4 | (1R,1'R,3aS,3'aS)-1,1'-(1,2-Phenylene)bis(hexahydro-2-phenyl-1H-pyrrolo(1,2-c)(1,3,2)diazaphosphole);ESPHOS | C28H32N4P2 |
| 254993-59-4 | 2-Chloro-4-trifluoromethylphenylboronic acid ;2-Chloro-4-(trifluoromethyl)phenylboronic acid | C7H5BClF3O2 |
| 255051-14-0 | 4-(2-Trifluoromethylphenyl)piperidine hydrochloride | C12H14F3N.HCl |